TP53 and cancer: In particular, a recent study examining ribosomal protein S14 (RPS14) and cancer concluded that this protein can specifically interact with murine double minute 2 (MDM2) to inhibit the degradation of p53 by MDM2 ubiquitin, thereby promoting p53 activity.